The synergetic effect of sitafloxacin–arbekacin combination in the Mycobacterium abscessus species

The synergetic effect of sitafloxacin–arbekacin combination in the Mycobacterium abscessus species

Abstract Mycobacterium abscessus species (MABS) is the most commonly isolated rapidly growing mycobacteria (RGM) and is one of the most antibiotic-resistant RGM with rapid progression, therefore, treatment of MABS is still challenging. We here presented a new combination treatment with sitafloxacin...

Full description

Bibliographic Details
Main Authors:	Junko Watanabe, Hiroaki Ihara, Satomi Takei, Ayako Nakamura, Yuichi Fujimoto, Tetsuya Handoh, Kana Kurokawa, Yuta Arai, Kohei Shibayama, Issei Sumiyoshi, Yusuke Ochi, Takahiro Okabe, Shigeki Misawa, Shinsaku Togo, Toshio Naito, Yoko Tabe, Takashi Miida, Kazuhisa Takahashi
Format:	Article
Language:	English
Published:	Nature Portfolio 2023-02-01
Series:	Scientific Reports
Online Access:	https://doi.org/10.1038/s41598-023-29021-0

Similar Items

Sitafloxacin Expresses Potent Anti-Mycobacterium abscessus Activity
by: Siyuan He, et al.
Published: (2022-01-01)

Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy
by: Takahiro Okabe, et al.
Published: (2020-11-01)

Severe Pulmonary Mycobacterium abscessus Cases Due to Co-Infection with Other Microorganisms Well Treated by Clarithromycin and Sitafloxacin in Japan
by: Takano K, et al.
Published: (2021-07-01)

High lymphocyte population-related predictive factors for a long-term response in non-small cell lung cancer patients treated with pemetrexed: a retrospective observational study
by: Issei Sumiyoshi, et al.
Published: (2021-02-01)

Torsades de pointes due to oral sitafloxacin
by: Yugo Wakayama, et al.
Published: (2023-01-01)

In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals
by: Julio C. R. Cordeiro, et al.

Doxycycline and Sitafloxacin Combination Therapy for Treating Highly Resistant Mycoplasma genitalium
by: Duygu Durukan, et al.
Published: (2020-08-01)

Arbekacin: another novel agent for treating infections due to methicillin-resistant Staphylococcus aureus and multidrug-resistant Gram-negative pathogens
by: Matsumoto T
Published: (2014-09-01)

Helicobacter pylori rescue treatment with vonoprazan, metronidazole, and sitafloxacin in the presence of penicillin allergy
by: Soichiro Sue, et al.
Published: (2021-02-01)

Sitafloxacin for Third-Line <i>Helicobacter pylori</i> Eradication: A Systematic Review
by: Toshihiro Nishizawa, et al.
Published: (2021-06-01)

Determination of MIC distribution of arbekacin, cefminox, fosfomycin, biapenem and other antibiotics against gram-negative clinical isolates in South India: a prospective study.
by: Sangeetha Rajenderan, et al.
Published: (2014-01-01)

Macrolides and mycobacterium abscessus abscessus: A good idea?
by: Ross John Langley, et al.
Published: (2018-01-01)

Investigation of the individual genetic evolution of SARS-CoV-2 in a small cluster during the rapid spread of the BF.5 lineage in Tokyo, Japan
by: Bo Jin, et al.
Published: (2023-09-01)

Antimicrobial activities of sitafloxacin and comparators against the clinical isolates of less common nonfermenting Gram-negative bacteria
by: Xun Zhou, et al.
Published: (2022-09-01)

Efficacy of triple therapy with esomeprazole, amoxicillin, and sitafloxacin as a third-line Helicobacter pylori eradication regimen
by: Yoshihiro Hirata, et al.
Published: (2016-10-01)

CT Guided Needle Biopsy of Peripheral Lesions–Lesion Characteristics That May Increase the Diagnostic Yield and Reduce the Complication Rate
by: Manabu Tajima, et al.
Published: (2021-05-01)

Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment
by: Satomi Takei, et al.
Published: (2022-01-01)

Performance evaluation of the Roche Elecsys® Anti-SARS-CoV-2 immunoassays by comparison with neutralizing antibodies and clinical assessment.
by: Satomi Takei, et al.
Published: (2022-01-01)

Mixed Infection of Mycobacterium abscessus subsp. abscessus and Mycobacterium tuberculosis in the Lung
by: Sungmin Sohn, et al.
Published: (2017-02-01)

Development of Bisphosphonate-Conjugated Antibiotics to Overcome Pharmacodynamic Limitations of Local Therapy: Initial Results with Carbamate Linked Sitafloxacin and Tedizolid
by: Emmanuela Adjei-Sowah, et al.
Published: (2021-06-01)

Vonoprazan-Based Third-Line Therapy Has a Higher Eradication Rate against Sitafloxacin-Resistant Helicobacter pylori
by: Yoshimasa Saito, et al.
Published: (2019-01-01)

Pulmonary infection due to fluoroquinolone-resistant Mycolicibacterium fortuitum: a case report
by: Kana Kurokawa, et al.
Published: (2020-11-01)

Mycobacterium abscessus subspecies abscessus infection associated with cosmetic surgical procedures: Case series
by: C. Moreno-Izquierdo, et al.
Published: (2020-01-01)

Lectures in synergetics /
by: 396540 Sugakov, Volodymyr I.
Published: (1998)

Synergetics of Dislocations
by: Kratochvil, J.
Published: (1993-06-01)

New Mycobacteroides abscessus subsp. massiliense strains with recombinant hsp65 gene laterally transferred from Mycobacteroides abscessus subsp. abscessus: Potential for misidentification of M. abscessus strains with the hsp65-based method.
by: Byoung-Jun Kim, et al.
Published: (2019-01-01)

Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China
by: Yaoyao Kong, et al.
Published: (2023-11-01)

Evidence of bisphosphonate-conjugated sitafloxacin eradication of established methicillin-resistant S. aureus infection with osseointegration in murine models of implant-associated osteomyelitis
by: Youliang Ren, et al.
Published: (2023-10-01)

Therapeutic Potential of Sitafloxacin as a New Drug Candidate for <i>Helicobacter</i> Eradication in Korea: An In Vitro Culture-Based Study
by: Youn I Choi, et al.
Published: (2021-10-01)

Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against Mycobacterium abscessus: Implication for patients with cystic fibrosis
by: John E Moore, et al.
Published: (2018-01-01)

Mycobacterium abscessus – to treat or not to treat?
by: Liam, C.K., et al.
Published: (2013)

Treatment of Mycobacterium abscessus Infection
by: Shannon A. Novosad, et al.
Published: (2016-03-01)

Nintedanib administration after the onset of acute exacerbation of interstitial lung disease in the real world
by: Motoyasu Kato, et al.
Published: (2023-08-01)

Colistin Monotherapy versus Colistin plus Sitafloxacin for Therapy of Carbapenem-Resistant <i>Acinetobacter baumannii</i> Infections: A Preliminary Study
by: Rujipas Sirijatuphat, et al.
Published: (2022-11-01)

Sitafloxacin- Versus Moxifloxacin-Based Sequential Treatment for Mycoplasma Genitalium Infections: Protocol for a Multicenter, Open-Label Randomized Controlled Trial
by: Naokatsu Ando, et al.
Published: (2023-11-01)

Efficacy of Bisphosphonate-Conjugated Sitafloxacin in a Murine Model of S. aureus Osteomyelitis: Evidence of “Target & Release” Kinetics and Killing of Bacteria Within Canaliculi
by: Youliang Ren, et al.
Published: (2022-06-01)

Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment.
by: Maika Takahashi, et al.
Published: (2023-01-01)

Performance evaluation of the Ortho VITROS SARS-CoV-2 Spike-Specific Quantitative IgG test by comparison with the surrogate virus neutralizing antibody test and clinical assessment
by: Maika Takahashi, et al.
Published: (2023-01-01)

Unusually high clarithromycin resistance in Mycobacterium abscessus subsp. abscessus isolated from human gastric epithelium
by: Deepak Chouhan, et al.
Published: (2023-08-01)

Mycobacterium abscessus subsp. abscessus Lung Disease: Drug Susceptibility Testing in Sputum Culture Negative Conversion
by: Takehiko Kobayashi, et al.
Published: (2018-01-01)